186 related articles for article (PubMed ID: 27617656)
1. Inverse correlation of soluble programmed cell death-1 ligand-1 (sPD-L1) with eosinophil count and clinical severity in allergic rhinitis patients.
Nasiri Kalmarzi R; Fattahi N; Kaviani Z; Ataee P; Mansouri M; Moradi G; Yousefzade A; Abbassi JM
Allergol Int; 2017 Apr; 66(2):326-331. PubMed ID: 27617656
[TBL] [Abstract][Full Text] [Related]
2. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637
[No Abstract] [Full Text] [Related]
3. The relationship between B7 homologous 1 with interleukin-4, interleukin-17 and interferon gamma in patients with allergic rhinitis.
Nasiri Kalmarzi R; Fakhimi R; Manouchehri F; Ataee P; Naleini N; Babaei E; Azadi N; Rabeti K; Kooti W
Expert Rev Clin Immunol; 2019 Aug; 15(8):897-901. PubMed ID: 31269820
[No Abstract] [Full Text] [Related]
4. Nasal smear eosinophils and allergic rhinitis.
Pal I; Sinha Babu A; Halder I; Kumar S
Ear Nose Throat J; 2017; 96(10-11):E17-E22. PubMed ID: 29121381
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma.
Wang L; Wang H; Chen H; Wang WD; Chen XQ; Geng QR; Xia ZJ; Lu Y
Oncotarget; 2015 Dec; 6(38):41228-36. PubMed ID: 26515600
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer.
Takahashi N; Iwasa S; Sasaki Y; Shoji H; Honma Y; Takashima A; Okita NT; Kato K; Hamaguchi T; Yamada Y
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1727-38. PubMed ID: 27256004
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble programmed death-1 and programmed death ligand-1 in systemic sclerosis: Association with extent of skin sclerosis.
Yanaba K; Hayashi M; Yoshihara Y; Nakagawa H
J Dermatol; 2016 Aug; 43(8):954-7. PubMed ID: 26945563
[TBL] [Abstract][Full Text] [Related]
8. Serum sPD-L1, Upregulated in Sepsis, May Reflect Disease Severity and Clinical Outcomes in Septic Patients.
Liu M; Zhang X; Chen H; Wang G; Zhang J; Dong P; Liu Y; An S; Wang L
Scand J Immunol; 2017 Jan; 85(1):66-72. PubMed ID: 27864994
[TBL] [Abstract][Full Text] [Related]
9. sPD-L1 Expression is Associated with Immunosuppression and Infectious Complications in Patients with Acute Pancreatitis.
Chen Y; Li M; Liu J; Pan T; Zhou T; Liu Z; Tan R; Wang X; Tian L; Chen E; Qu H
Scand J Immunol; 2017 Aug; 86(2):100-106. PubMed ID: 28513984
[TBL] [Abstract][Full Text] [Related]
10. [Increased serum levels of soluble programmed death-1 (sPD-1) and sPD-ligand 1 in patients infected with Brucella].
Pang P; Zhu Y; Jia B; Yang Y; Hu J; Zhang Y; Zhang F; Ding J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Dec; 32(12):1675-1678. PubMed ID: 27916101
[TBL] [Abstract][Full Text] [Related]
11. Functional variants of 17q12-21 are associated with allergic asthma but not allergic rhinitis.
Andiappan AK; Sio YY; Lee B; Suri BK; Matta SA; Lum J; Foo S; Koh G; Liu J; Zolezzi F; Poidinger M; Wang de Y; Rotzschke O; Chew FT
J Allergy Clin Immunol; 2016 Mar; 137(3):758-66.e3. PubMed ID: 26483175
[TBL] [Abstract][Full Text] [Related]
12. High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis.
Finkelmeier F; Canli Ö; Tal A; Pleli T; Trojan J; Schmidt M; Kronenberger B; Zeuzem S; Piiper A; Greten FR; Waidmann O
Eur J Cancer; 2016 May; 59():152-159. PubMed ID: 27039170
[TBL] [Abstract][Full Text] [Related]
13. Increased PD-1 on CD4(+)CD28(-) T cell and soluble PD-1 ligand-1 in patients with T2DM: association with atherosclerotic macrovascular diseases.
Shi B; Du X; Wang Q; Chen Y; Zhang X
Metabolism; 2013 Jun; 62(6):778-85. PubMed ID: 23398844
[TBL] [Abstract][Full Text] [Related]
14. Validation of the modified allergic rhinitis and its impact on asthma (ARIA) severity classification in allergic rhinitis children: the PEDRIAL study.
Montoro J; Del Cuvillo A; Mullol J; Molina X; Bartra J; Dávila I; Ferrer M; Jáuregui I; Sastre J; Valero A
Allergy; 2012 Nov; 67(11):1437-42. PubMed ID: 22985483
[TBL] [Abstract][Full Text] [Related]
15. Correlation of immunoglobulin E, eosinophil cationic protein, and eosinophil count with the severity of childhood perennial allergic rhinitis.
Chen ST; Sun HL; Lu KH; Lue KH; Chou MC
J Microbiol Immunol Infect; 2006 Jun; 39(3):212-8. PubMed ID: 16783451
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of soluble programmed death-1 (sPD-1) and soluble programmed death ligand 1(sPD-L1) in systemic lupus erythematosus: Association with activity and severity.
Du Y; Nie L; Xu L; Wu X; Zhang S; Xue J
Scand J Immunol; 2020 Jul; 92(1):e12884. PubMed ID: 32243638
[TBL] [Abstract][Full Text] [Related]
17. The correlation between nasal symptom and mucociliary clearance in allergic rhinitis.
Kirtsreesakul V; Somjareonwattana P; Ruttanaphol S
Laryngoscope; 2009 Aug; 119(8):1458-62. PubMed ID: 19507239
[TBL] [Abstract][Full Text] [Related]
18. Serum Immunoglobulin E Level and Its Relationship with Eosinophil Count among Patients with Allergic Rhinitis in Tertiary Hospital in Bauchi, Northeastern Nigeria: A Cross-Sectional Study.
Gwalabe SA; Adamu A; Kirfi AM; Dunga JA; Maigari IM
Niger J Clin Pract; 2024 Mar; 27(3):389-393. PubMed ID: 38528361
[TBL] [Abstract][Full Text] [Related]
19. Elevated Serum Level of CD48 in Patients with Intermittent Allergic Rhinitis.
Branicka O; Jura-Szołtys E; Rogala B; Glück J
Int Arch Allergy Immunol; 2021; 182(1):39-48. PubMed ID: 32966985
[TBL] [Abstract][Full Text] [Related]
20. Is neutrophil-lymphocyte ratio associated with the severity of allergic rhinitis in children?
Dogru M; Evcimik MF; Cirik AA
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3175-8. PubMed ID: 26525883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]